The Target 2035 webinar series highlight relevant research topics with a mixture of talks and discussions by prominent scientific leaders and young scientists giving their perspectives and demonstrating the latest enabling technologies.
This Target 2035 webinar focus on Targeted Protein Degradation, provides insight on the development of degraders and how they can be used in the clinic in two talks from George Winter (CeMM) and Danette Daniels (Foghorn Therapeutics). The webinar is hosted by the Biological Discovery through Chemical Innovation (BDCI) initiative at Emory University.
